Inspections, Compliance, Enforcement, and Criminal Investigations

Green Supreme Inc. - Close Out Letter 7/27/16

  

Department of Health and Human Services' logoDepartment of Health and Human Services

Philadelphia District Office
 Food and Drug Administration
900 U.S. Customhouse
2nd and Chestnut Street
Philadelphia, PA 19106

Telephone: 215-597-4390

CERTIFIED MAIL
RETURN RECEIPT REQUESTED

July 27, 2016
 

Nyron L. Ligo, Owner
Green Supreme, Inc.
3647 New Castle Road
West Middlesex, PA 16159

Dear Mr. Ligo:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 16-PHI-02 issued on January 15, 2016. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,

/S/

Steven L. Carter
Director, Compliance Branch
Philadelphia District Office

Page Last Updated: 08/02/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English